Carlyle Group Inc. Q4 2025 Filing

Filed February 13, 2026

Portfolio Value

$13.6B

Holdings

20

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (20 positions)

#StockSharesValue% PortfolioType
1
MDLNMedline Inc
215,303,036$9.0B66.65%
2
SAROStandardaero Inc
152,673,891$4.4B32.27%
3
PHATPhathom Pharmaceuticals Inc
3,496,808$58.0M0.43%
4
PONYPony Ai Inc
2,362,447$34.3M0.25%
5
INVHInvitation Homes Inc
664,100$18.5M0.14%
6
GETYGetty Images Holdings Inc
6,234,252$8.4M0.06%
7
CUBECubeSmart
220,500$7.9M0.06%
8
QTTBQ32 Bio Inc
1,102,741$3.6M0.03%
9
SPRBSpruce Biosciences Inc
38,620$3.3M0.02%
10
FWRDForward Air Corp
107,214$3.1M0.02%
11
JSPRJasper Therapeutics Inc
1,066,189$1.9M0.01%
12
ACETAdicet Bio Inc
184,295$1.5M0.01%
13
DNUTKrispy Kreme Inc
340,748$1.4M0.01%
14
OKUROnkure Therapeutics Inc
269,895$771K0.01%
15
NABLN-able Inc
93,732$701K0.01%
16
SPWRSunPower Inc
433,158$680K0.01%
17
NCNANucana Plc
133,333$479K0.00%
18
HOODRobinhood Mkts Inc
3,376$381K0.00%
19
SYRESpyre Therapeutics Inc
9,620$315K0.00%
20
XCURExicure Inc
56,328$304K0.00%